Renal Osteodystrophy: A Fresh Approach



Status:Completed
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:7/11/2015
Start Date:March 2009
End Date:February 2014

Use our guide to learn which trials are right for you!

There are two major goals of this project:

1. Comparison of DXA and QCT for diagnosis of bone loss in CKD-5 patients and
determination of the prevalence of low bone turnover in CKD-5 patients with bone loss.

2. Identification of the optimal combination of noninvasive tests for definition of the
turnover component of ROD.


Inclusion Criteria:

- Aged 18 years or older;

- Chronic maintenance dialysis of at least 3 months' duration;

- Mental competence;

- Willingness to participate in the study;

- Calcidiol levels within normal range.

Exclusion Criteria:

- Pregnancy;

- Systemic illnesses or organ diseases that may affect bone (except type 1 or type 2
diabetes mellitus);

- Clinical condition that may limit study participation (e.g., unstable angina,
respiratory distress, infections).

- Chronic alcoholism and/or drug addiction;

- Participation in a study of an investigational drug during the past 90 days;

- Allergy to tetracycline.

- Planning to move out of the area within 2 years of the study;

- On active transplant list;

- Treatment within last 6 months with drugs that may affect bone metabolism (except for
treatment with calcitriol, vitamin D analogs and/or calcimimetics).

- Calcidiol level below the normal range. The current routine clinical practice in our
dialysis clinics is to check calcidiol status twice yearly and supplement with
vitamin D according to serum calcidiol levels. It is therefore unlikely that a
substantial number of patients will be excluded due to this exclusion criterion.
We found this trial at
1
site
Lexington, Kentucky
859) 257-9000
University of Kentucky The University of Kentucky is a public, land grant university dedicated to...
?
mi
from
Lexington, KY
Click here to add this to my saved trials